Target intelligence / Profile preview

Centrosome and spindle pole–associated protein 1 (CSPP1)

Target
CSPP1
Molecular classification
Other (Microtubule-associated protein)
01

Overview

Centrosome and spindle pole–associated protein 1 (CSPP1) is a multifunctional microtubule-associated protein that localizes to centrosomes, spindle poles, kinetochores, and ciliary axonemes[1][3][4]. It is essential for cell cycle progression, spindle assembly, accurate chromosome segregation during mitosis, and cilia formation[1][4][5]. CSPP1 stabilizes microtubules by directly binding both their plus and minus ends, acting as a unique dual-end capping factor that preserves microtubule integrity, particularly in non-dividing and differentiated cells[2][3]. Mutations in CSPP1 lead to ciliopathies such as Joubert syndrome and may play roles in cancer biology, as aberrations in CSPP1 function are implicated in chromosomal instability and tumorigenesis[1][4][5]. CSPP1 is also considered a molecular marker for some subtypes of breast carcinoma[4]. Key details: - CSPP1 is not currently considered a direct therapeutic target or druggable protein; its primary significance is in disease biology and cell structure/cycle regulation, not as a receptor, enzyme, or transporter[1][5]. - Mutations are associated with severe developmental disorders, most notably Joubert syndrome, which feature ciliary defects[1][3][5]. - No drugs are currently known to interact directly with CSPP1, nor are there established mechanisms of drug action for this protein[5].

Other names
CSPPFLJ22490CSPP-LJBTS21centrosome and spindle pole–associated protein 1
02

Biological functions

Cell cycleSpindle organizationCytokinesisMicrotubule stabilizationCiliogenesis
03

Disease associations

CancerCiliopathies (including Joubert syndrome)
04

Safety considerations

Cancer risk associated with altered expression or mutationDevelopmental disorders due to defective cilia formation
05

Biomarkers

Molecular marker for basal-like breast carcinoma

Beyond the preview

Go deeper on Centrosome and spindle pole–associated protein 1 (CSPP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Centrosome and spindle pole–associated protein 1 (CSPP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call